Related Experiment Video
Updated: May 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies
M Thomsen1, B G Nordestgaard, A A Sethi
1Dept of Clinical Biochemistry, Herlev Hospital, Herlev, Denmark.
The ADRB2 Thr164Ile gene variant is linked to poorer lung function and a higher risk of chronic obstructive pulmonary disease (COPD). This finding is based on genetic analysis of over 60,000 individuals, highlighting a significant association in the general population.
Area of Science:
- Genetics and Respiratory Medicine
- Pharmacogenomics of Adrenergic Receptors
Background:
- The beta-2 adrenergic receptor (ADRB2) plays a crucial role in regulating airway smooth muscle tone.
- Genetic variations in the ADRB2 gene may influence lung function and susceptibility to respiratory diseases.
Purpose of the Study:
- To investigate the association between three functional polymorphisms in the ADRB2 gene (Thr164Ile, Gly16Arg, and Gln27Glu) and lung function, asthma, and COPD.
- Specifically, to examine the impact of the Thr164Ile polymorphism on lung function parameters and COPD risk.
Main Methods:
- Genotyping of 8,971 individuals from the Copenhagen City Heart Study for three ADRB2 polymorphisms.
- Validation genotyping of 53,777 individuals from the Copenhagen General Population Study for the Thr164Ile polymorphism.
- Statistical analysis to assess the association between genotypes and lung function (FEV(1)% predicted, FEV(1)/FVC) and COPD prevalence.
Main Results:
- The ADRB2 Thr164Ile genotype was significantly associated with reduced FEV(1)% predicted and FEV(1)/FVC in both study cohorts.
- Heterozygotes for Thr164Ile showed a 3% and 2% reduction in FEV(1)% pred and FEV(1)/FVC, respectively, in the Copenhagen City Heart Study.
- In the Copenhagen General Population Study, Thr164Ile homozygotes and heterozygotes exhibited reduced FEV(1)% pred and FEV(1)/FVC.
- An increased odds ratio for COPD was observed in Thr164Ile heterozygotes (1.46) in the Copenhagen City Heart Study and in homozygotes (4.53) in the Copenhagen General Population Study.
Conclusions:
- The ADRB2 Thr164Ile polymorphism is associated with diminished lung function.
- This genetic variant is linked to an increased risk of developing chronic obstructive pulmonary disease (COPD) in the general population.
- These findings underscore the role of ADRB2 genetic variations in respiratory health and disease susceptibility.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction